Hesperidin Suppressed Colorectal Cancer through Inhibition of Glycolysis
Chinese Journal of Integrative Medicine · 2025
DOI: 10.1007/s11655-024-4113-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Journal of Integrative Medicine, 2025. Verfasst von Ke-Xiang Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China. Hauptthemen laut MEDLINE: Hesperidin, Colorectal Neoplasms, Glycolysis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To explore the role of the natural compound hesperidin in glycolysis, the key ratelimiting enzyme, in colorectal cancer (CRC) cell lines. METHODS: In vitro, HCT116 and SW620 were treated with different doses of hesperidin (0-500 µmol/L), cell counting kit-8 and colone formation assays were utilized to detected inhibition effect of hesperidin on CRC cell lines. Transwell and wound healing assays were performed to detect the ability of hesperidin (0, 25, 50 and 75 µmol/L) to migrate CRC cells. To confirm the apoptotic-inducing effect of hesperidin, apoptosis and cycle assays were employed. Western blot, glucose uptake, and lactate production determination measurements were applied to determine inhibitory effects of hesperidin (0, 25 and 50 µmol/L) on glycolysis. In vivo, according to the random number table method, nude mice with successful tumor loading were randomly divided into vehicle, low-dose hesperidin (20 mg/kg) and high-dose hesperidin (60 mg/kg) groups, with 6 mice in each group. The body weights and tumor volumes of mice were recorded during 4-week treatment. The expression of key glycolysis rate-limiting enzymes was determined using Western blot, and glucose uptake and lactate production were assessed. Finally, protein interactions were probed with DirectDIA Quantitative Proteomics, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. RESULTS: Hesperidin could inhibit CRC cell line growth (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China.
- Department of Medical Oncology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China. tcmdwl@163.com.
Zitieren
APA
Sun, K. X., Tan, W. S., Wang, H. Y., Gao, J. M., Wang, S. Y., Xie, M. L., & Deng, W. L. (2025). Hesperidin Suppressed Colorectal Cancer through Inhibition of Glycolysis. Chinese Journal of Integrative Medicine. https://doi.org/10.1007/s11655-024-4113-x
Vancouver
Sun KX, Tan WS, Wang HY, Gao JM, Wang SY, Xie ML, et al. Hesperidin Suppressed Colorectal Cancer through Inhibition of Glycolysis. Chinese Journal of Integrative Medicine. 2025. doi:10.1007/s11655-024-4113-x
BibTeX
@article{Sun2025,
author = {Sun, Ke-Xiang and Tan, Wei-Shan and Wang, Hao-Yue and Gao, Jia-Min and Wang, Shu-Yun and Xie, Man-Li and Deng, Wan-Li},
title = {Hesperidin Suppressed Colorectal Cancer through Inhibition of Glycolysis},
journal = {Chinese Journal of Integrative Medicine},
year = {2025},
doi = {10.1007/s11655-024-4113-x}
}
EUVIMED